当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

  

流通市值:2332.55亿  总市值:2813.98亿
流通股本:24.73亿   总股本:29.84亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金34,327,532,724.9222,710,907,108.6110,887,895,827.6241,023,171,534.69
  收到的税费返还1,093,800,903.48812,228,117.9496,033,127.371,426,098,831.35
  收到其他与经营活动有关的现金690,144,986.47532,873,783.14256,410,492.71,015,938,369.1
  经营活动现金流入小计36,111,478,614.8724,056,009,009.6511,640,339,447.6943,465,208,735.14
  购买商品、接受劳务支付的现金13,228,850,010.168,617,574,553.833,720,501,702.7215,075,656,437.5
  支付给职工以及为职工支付的现金7,928,078,759.925,770,875,505.753,455,707,702.0710,752,651,632.33
  支付的各项税费2,160,136,328.871,342,576,723.44669,843,245.53,131,836,919.54
  支付其他与经营活动有关的现金1,381,578,848.45894,000,694.93598,856,935.682,098,548,911.18
  经营活动现金流出小计24,698,643,947.416,625,027,477.958,444,909,585.9731,058,693,900.55
  经营活动产生的现金流量净额11,412,834,667.477,430,981,531.73,195,429,861.7212,406,514,834.59
二、投资活动产生的现金流量:
  收回投资收到的现金11,163,983,140.146,847,023,306.042,801,642,393.5411,490,069,612.54
  取得投资收益收到的现金237,240,096.6258,168,449.9520,004,957.84482,075,411.66
  处置固定资产、无形资产和其他长期资产收回的现金净额9,761,249.999,375,735.071,678,587.4715,837,544.06
  处置子公司及其他营业单位收到的现金净额1,343,881,409.161,255,520,822.861,255,520,822.86-
  投资活动现金流入小计12,754,865,895.918,170,088,313.924,078,846,761.7111,987,982,568.26
  购建固定资产、无形资产和其他长期资产支付的现金3,566,317,746.462,101,763,801.59734,534,627.094,003,492,547.65
  投资支付的现金8,783,584,477.764,258,782,879.041,144,555,938.9513,502,667,147.36
  投资活动现金流出小计12,349,902,224.226,360,546,680.631,879,090,566.0417,506,159,695.01
  投资活动产生的现金流量净额404,963,671.691,809,541,633.292,199,756,195.67-5,518,177,126.75
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,995,823,546.01--196,427,943.88
  取得借款收到的现金11,575,750,138.887,677,208,916.664,767,126,048.98,268,427,336.78
  发行债券收到的现金---3,521,497,254.53
  筹资活动现金流入小计18,571,573,684.897,677,208,916.664,767,126,048.911,986,352,535.19
  偿还债务支付的现金8,718,797,498.615,222,657,871.553,408,720,026.728,470,159,769.43
  分配股利、利润或偿付利息支付的现金4,966,801,138.593,915,938,314.759,416,181.893,084,876,631.26
  其中:子公司支付给少数股东的股利、利润23,518,29021,980,66415,830,160-
  支付其他与筹资活动有关的现金4,463,317,745.013,467,940,039.8262,953,208.744,263,506,782.53
  筹资活动现金流出小计18,148,916,382.2112,606,536,226.073,531,089,417.3515,818,543,183.22
  筹资活动产生的现金流量净额422,657,302.68-4,929,327,309.411,236,036,631.55-3,832,190,648.03
四、汇率变动对现金及现金等价物的影响-209,209,966.1-203,423,250.66-61,078,422.61387,525,345.81
五、现金及现金等价物净增加额12,031,245,675.744,107,772,604.926,570,144,266.333,443,672,405.62
  加:期初现金及现金等价物余额13,444,711,217.6413,444,711,217.6413,444,711,217.6410,001,038,812.02
  期末现金及现金等价物余额25,475,956,893.3817,552,483,822.5620,014,855,483.9713,444,711,217.64
补充资料:
  净利润-8,660,348,120.54-9,567,739,539.18
  资产减值准备-321,420,123.36-1,236,257,969.76
  固定资产和投资性房地产折旧-1,527,089,686.4-2,372,311,085.1
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,527,089,686.4-2,372,311,085.1
  无形资产摊销-68,534,477.74-164,533,512.69
  长期待摊费用摊销-49,264,471.95-231,657,383.2
  处置固定资产、无形资产和其他长期资产的损失-12,844,822.74-36,063,443.51
  固定资产报废损失-2,485,850.82-6,234,193.27
  公允价值变动损失-182,183,014.07--186,957,574.92
  财务费用-522,731,890.77--428,033,421.6
  投资损失--3,669,213,003.27--604,162,381.66
  递延所得税--137,723,370.66--44,156,932.49
  其中:递延所得税资产减少--69,001,444.91--90,765,548.73
    递延所得税负债增加--68,721,925.75-46,608,616.24
  存货的减少--1,800,680,510.95--914,170,842.65
  经营性应收项目的减少-657,038,345.86--779,189,585.3
  经营性应付项目的增加-515,774,644.13-767,141,307.65
  其他-212,203,859.97-366,914,923.65
  现金的期末余额-17,552,483,822.56-13,444,711,217.64
  减:现金的期初余额-13,444,711,217.64-10,001,038,812.02
  现金及现金等价物的净增加额-4,107,772,604.92-3,443,672,405.62
公告日期2025-10-272025-07-292025-04-292025-03-18
审计意见(境内)标准无保留意见
TOP↑